Piperacillin-Tazobactam vs Cefoxitin Prophylaxis for Pancreatoduodenectomy
JAMA · 2023
DOI: 10.1001/jama.2023.12773 ↗Kurz gefasst
Leserbrief in der Zeitschrift JAMA, 2023. Verfasst von Ziyi Yang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China. Hauptthemen laut MEDLINE: Cefoxitin, Pancreaticoduodenectomy, Piperacillin, Tazobactam Drug Combination, Antibiotic Prophylaxis. Die Arbeit nennt 4 Literaturangaben.
Abstract (Originalsprache)
To the Editor A recent study1 found that antimicrobial prophylaxis with piperacillin-tazobactam was associated with lower rates of SSI and clinically relevant postoperative pancreatic fistula than cefoxitin in patients undergoing pancreatoduodenectomy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of General Surgery, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Zitieren
APA
Yang, Z., Mei, J., & Gong, W. (2023). Piperacillin-Tazobactam vs Cefoxitin Prophylaxis for Pancreatoduodenectomy. JAMA. https://doi.org/10.1001/jama.2023.12773
Vancouver
Yang Z, Mei J, Gong W. Piperacillin-Tazobactam vs Cefoxitin Prophylaxis for Pancreatoduodenectomy. JAMA. 2023. doi:10.1001/jama.2023.12773
BibTeX
@article{Yang2023,
author = {Yang, Ziyi and Mei, Jiawei and Gong, Wei},
title = {Piperacillin-Tazobactam vs Cefoxitin Prophylaxis for Pancreatoduodenectomy},
journal = {JAMA},
year = {2023},
doi = {10.1001/jama.2023.12773}
}
EUVIMED